JAMIE MADL: Open Payments
NPI 1972903813 · LAWRENCE, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,098 in 51 payments from 13 companies in 2025. Trend: 2023 $638 · 2024 $814 · 2025 $1,098
Food & beverage: $1,098
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $399 |
| Regeneron Healthcare Solutions, Inc. | 5 | $146 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $146 |
| Celltrion USA Inc. | 4 | $128 |
| Janssen Biotech, Inc. | 3 | $75 |
| Ardelyx, Inc. | 2 | $42 |
| Intercept Pharmaceuticals, Inc. | 2 | $35 |
| Lilly USA, LLC | 1 | $33 |
| SHIELD THERAPEUTICS INC | 1 | $25 |
| IRONWOOD PHARMACEUTICALS, INC | 1 | $18 |
Products named: SKYRIZI, RINVOQ, DUPIXENT, VEGZELMA, ENTYVIO, TREMFYA, IBSRELA, EOHILIA.
Industry payments across KS — which companies pay providers there.
